Edmond de Rothschild leads €23m Pangenetics investment
Edmond de Rothschild Investment Partners has led a €23m third round of funding for PanGenetics.
Biogen
Edmond de Rothschild Investment Partners has led a €23m third round of funding for PanGenetics.
Biogen